Multicenter, single-arm, phase II trial of camrelizumab and chemotherapy as neoadjuvant treatment for locally advanced esophageal squamous cell carcinoma (vol 10, e004291, 2022)

被引：0
|
作者：
Liu, J.
Yang, Y.
Liu, Z.
机构：
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2022年 / 10卷 / 06期
关键词：
D O I：
10.1136/jitc-2021-004291corr1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Neoadjuvant sintilimab plus chemotherapy for locally advanced esophageal squamous cell carcinoma: a single-arm, single-center, phase 2 trial (ESONICT-1)
    Zhang, Zhenyang
    Hong, Zhi-Nuan
    Xie, Shuhan
    Lin, Wenwei
    Lin, Yukang
    Zhu, Jiafu
    Yang, Xiaojie
    Lin, Zhiwei
    Lin, Jiangbo
    Kang, Mingqiang
    ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (21)
  • [32] Neoadjuvant Chemoimmunotherapy for the Treatment of Locally Advanced Head and Neck Squamous Cell Carcinoma: A Single-Arm Phase 2 Clinical Trial
    Zhang, Zhanjie
    Wu, Bian
    Peng, Gang
    Xiao, Guixiang
    Huang, Jing
    Ding, Qian
    Yang, Chengzhang
    Xiong, Xingao
    Ma, Hui
    Shi, Liangliang
    Yang, Jinsong
    Hong, Xiaohua
    Wei, Jielin
    Qin, You
    Wan, Chao
    Zhong, Yi
    Zhou, Yan
    Zhao, Xueyan
    Leng, Yangming
    Zhang, Tao
    Wu, Gang
    Yao, Min
    Zhang, Xiaomeng
    Yang, Kunyu
    CLINICAL CANCER RESEARCH, 2022, 28 (15) : 3268 - 3276
  • [33] Camrelizumab combined with paclitaxel and nedaplatin as neoadjuvant therapy for locally advanced esophageal squamous cell carcinoma (ESPRIT): A phase., single-arm, exploratory research.
    Ma, Jianqun
    Zhang, Jinfeng
    Yang, Yingnan
    Zheng, Dayong
    Wang, Xiaoyuan
    Liang, Hao
    Zhang, Luquan
    Xin, Yanzhong
    Ling, Xiaodong
    Fang, Chengyuan
    Jiang, Hao
    Zheng, Wei
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [34] A phase II, single-centre trial of neoadjuvant toripalimab plus chemotherapy in locally advanced esophageal squamous cell carcinoma
    Xing, Wenqun
    Zhao, Lingdi
    Fu, Xiaomin
    Liang, Guanghui
    Zhang, Yong
    Yuan, Dongfeng
    Li, Zhenxuan
    Gao, Quanli
    Zheng, Yan
    JOURNAL OF THORACIC DISEASE, 2020, 12 (11) : 6861 - 6867
  • [35] Camrelizumab plus chemotherapy as neoadjuvant therapy for resectable, locally advanced esophageal squamous cell carcinoma (NIC-ESCC2019): A multicenter, open-label, single-arm, phase 2 study.
    Li, Jingpei
    Liu, Jun
    Li, Zhuoyi
    Cui, Fei
    Zeng, Yuan
    Liang, Wenhua
    Liang, Hengrui
    Wang, Wei
    Xu, Ke
    Cai, Weipeng
    Fu, JunHui
    He, Jianxing
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [36] The efficacy and safety of neoadjuvant camrelizumab and chemotherapy for locally advanced thoracic esophageal squamous cell carcinoma
    Xu, Weili
    Jiang, Youhua
    Wang, Changchun
    Wu, Jie
    Li, Jianqiang
    Hu, Yuqian
    Lu, Weishan
    Shen, Dijian
    Wang, Yinjie
    Chen, Qixun
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [37] Camrelizumab combined with apatinib as neoadjuvant therapy for locally advanced esophageal squamous cell carcinoma: A phase 2 trial
    Meng, Xiangrui
    Qi, Yu
    Shan, Zhengzheng
    Yang, Yang
    Fan, Qingxia
    Wang, Feng
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [38] Clinical study on the second-line treatment of advanced esophageal squamous cell carcinoma with camrelizumab combined with apatinib and irinotecan: A single-arm, multicenter, phase II study
    He, Yifu
    Li, Chenghui
    Zhang, Fenglin
    Hu, Bing
    Sun, Yubei
    Xia, Xiaoyang
    Zhang, Yanshun
    Wang, Gang
    Xu, Tengyun
    Duan, Aixiong
    Wu, Shusheng
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [39] Prediction for major pathologic response after neoadjuvant tislelizumab combined with chemotherapy in patients with locally advanced esophageal squamous cell carcinoma by RNA sequencing: A single-arm, phase II trial
    Guo, Wei
    Wang, YingJian
    He, Yan
    Li, Kunkun
    Bao, Tao
    He, Xiandong
    Xie, Xianfeng
    Chen, Xv
    Pu, Xiangshu
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [40] Perioperative tislelizumab plus chemotherapy for locally advanced resectable thoracic esophageal squamous cell carcinoma trial: a prospective single-arm, phase II study (PILOT trial)
    Ding, Chengzhi
    Guo, Yijun
    Zhou, Yaning
    He, Yi
    Chen, Chunji
    Zhang, Ming
    Guo, Xufeng
    BMC CANCER, 2023, 23 (01)
12345